An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients

Conditions: Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer) Interventions: Drug: Allogeneic NK （CCT-ANK-11) Sponsors: Escure Biotechnology Corp; Beijing Kejing Biotechnology Corp. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials